Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HUMAN HEPATIC MICROSOMES' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 32 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jannetto, PJ; Antholine, WE; Myers, CR
      Cytochrome b(5) plays a key role in human microsomal chromium(VI) reduction

      TOXICOLOGY
    2. Hartter, S; Ursing, C; Morita, S; Tybring, G; von Bahr, C; Christensen, M; Rojdmark, S; Bertilsson, L
      Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: A pilot study

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    3. Ratain, MJ
      Insights into the pharmacokinetics and pharmacodynamics of irinotecan

      CLINICAL CANCER RESEARCH
    4. Kehrer, DFS; Yamamoto, W; Verweij, J; de Jonge, MJA; de Bruijn, P; Sparreboom, A
      Factors involved in prolongation of the terminal disposition phase of SN-38: Clinical and experimental studies

      CLINICAL CANCER RESEARCH
    5. Ma, MK; Zamboni, WC; Radomski, KM; Furman, WL; Santana, VM; Houghton, PJ; Hanna, SK; Smith, AK; Stewart, CF
      Pharmacokinetics of irinotecan and its metabolites SN-38 and ABC in children with recurrent solid tumors after protracted low-dose irinotecan

      CLINICAL CANCER RESEARCH
    6. Ong, CE; Coulter, S; Birkett, DJ; Bhasker, CR; Miners, JO
      The xenobiotic inhibitor profile of cytochrome P4502C8

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    7. Slatter, JG; Schaaf, HJ; Sams, JP; Feenstra, KL; Johnson, MG; Bombardt, PA; Cathcart, KS; Verburg, MT; Pearson, LK; Compton, LD; Miller, LL; Baker, DS; Pesheck, CV; Lord, RS
      Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following i.v. infusion of [C-14]CPT-11 in cancer patients

      DRUG METABOLISM AND DISPOSITION
    8. Nadin, L; Murray, M
      Arachidonic acid-mediated cooxidation of all-trans-retinoic acid in microsomal fractions from human liver

      BRITISH JOURNAL OF PHARMACOLOGY
    9. Chida, M; Yokoi, T; Fukui, T; Kinoshita, M; Yokota, J; Kamataki, T
      Detection of three genetic polymorphisms in the 5 '-flanking region and intron 1 of human CYP1A2 in the Japanese population

      JAPANESE JOURNAL OF CANCER RESEARCH
    10. Jinno, H; Hatakeyama, N; Hanioka, N; Yoda, R; Nishimura, T; Ando, M
      Cytotoxic and porphyrinogenic effects of diphenyl ethers in cultured rat hepatocytes: Chlornitrofen (CNP), CNP-amino, chlomethoxyfen and bifenox

      FOOD AND CHEMICAL TOXICOLOGY
    11. Nakajima, M; Yokoi, T; Mizutani, M; Kinoshita, M; Funayama, M; Kamataki, T
      Genetic polymorphism in the 5 '-flanking region of human CYP1A2 gene: Effect on the CYP1A2 inducibility in humans

      JOURNAL OF BIOCHEMISTRY
    12. Nadin, L; Murray, M
      Participation of CYP2C8 in retinoic acid 4-hydroxylation in human hepatic microsomes

      BIOCHEMICAL PHARMACOLOGY
    13. COLVIN ME; HATCH FT; FELTON JS
      CHEMICAL AND BIOLOGICAL FACTORS AFFECTING MUTAGEN POTENCY

      Mutation research. Fundamental and molecular mechanisms of mutagenesis
    14. ZALKO D; PERDUDURAND E; DEBRAUWER L; BECFERTE MP; TULLIEZ J
      COMPARATIVE METABOLISM OF CLENBUTEROL BY RAT AND BOVINE LIVER-MICROSOMES AND SLICES

      Drug metabolism and disposition
    15. HLAVICA P; GOLLY I; LEHNERER M; SCHULZE J
      PRIMARY AROMATIC-AMINES - THEIR N-OXIDATIVE BIOACTIVATION

      Human & experimental toxicology
    16. WOODCROFT KJ; WEBB CD; YAO M; WEEDON AC; BEND JR
      METABOLISM OF THE CYTOCHROME-P450 MECHANISM-BASED INHIBITOR N-BENZYL-1-AMINOBENZOTRIAZOLE TO PRODUCTS THAT COVALENTLY BIND WITH PROTEIN IN GUINEA-PIG LIVER AND LUNG MICROSOMES - COMPARATIVE-STUDY WITH 1-AMINOBENZOTRIAZOLE

      Chemical research in toxicology
    17. PADMA PR; OESCHBARTLOMOWICZ B; HENGSTLER JG; OESCH F
      CONTROL OF THE MUTAGENICITY OF ARYLAMINES BY PROTEIN-KINASES AND PHOSPHATASES .2. LACK OF RESPONSE OF RAT-LIVER N-ACETYL TRANSFERASES TO PHOSPHORYLATION MODULATORS

      Archives of toxicology
    18. BERTZ RJ; GRANNEMAN GR
      USE OF IN-VITRO AND IN-VIVO DATA TO ESTIMATE THE LIKELIHOOD OF METABOLIC PHARMACOKINETIC INTERACTIONS

      Clinical pharmacokinetics
    19. BOUSKA JJ; BELL RL; GOODFELLOW CL; STEWART AO; BROOKS CDW; CARTER GW
      IMPROVING THE IN-VIVO DURATION OF 5-LIPOXYGENASE INHIBITORS - APPLICATION OF AN IN-VITRO GLUCURONOSYLTRANSFERASE ASSAY

      Drug metabolism and disposition
    20. LAKSHMI VM; ZENSER TV; DAVIS BB
      RAT-LIVER CYTOCHROME-P450 METABOLISM OF N-ACETYLBENZIDINE AND N,N'-DIACETYLBENZIDINE

      Drug metabolism and disposition
    21. FITZSIMMONS ME; COLLINS JM
      SELECTIVE BIOTRANSFORMATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE INHIBITOR SAQUINAVIR BY HUMAN SMALL-INTESTINAL CYTOCHROME P4503A4 - POTENTIAL CONTRIBUTION TO HIGH FIRST-PASS METABOLISM

      Drug metabolism and disposition
    22. MAUREL P
      THE USE OF ADULT HUMAN HEPATOCYTES IN PRIMARY CULTURE AND OTHER IN-VITRO SYSTEMS TO INVESTIGATE DRUG-METABOLISM IN MAN

      Advanced drug delivery reviews
    23. LAKSHMI VM; ZENSER NT; HSU FF; MATTAMMAL MB; ZENSER TV; DAVIS BB
      NADPH-DEPENDENT OXIDATION OF BENZIDINE BY RAT-LIVER

      Carcinogenesis
    24. MCKINNON RA; MCMANUS ME
      LOCALIZATION OF CYTOCHROMES P450 IN HUMAN TISSUES - IMPLICATIONS FOR CHEMICAL TOXICITY

      Pathology
    25. EATON DL; GALLAGHER EP; BAMMLER TK; KUNZE KL
      ROLE OF CYTOCHROME P4501A2 IN CHEMICAL CARCINOGENESIS - IMPLICATIONS FOR HUMAN VARIABILITY IN EXPRESSION AND ENZYME-ACTIVITY

      Pharmacogenetics
    26. BOIS FY; KROWECH G; ZEISE L
      MODELING HUMAN INTERINDIVIDUAL VARIABILITY IN METABOLISM AND RISK - THE EXAMPLE OF 4-AMINOBIPHENYL

      Risk analysis
    27. SCHWARTZ EL; HALLAM S; GALLAGHER RE; WIERNIK PH
      INHIBITION OF ALL-TRANS-RETINOIC ACID METABOLISM BY FLUCONAZOLE IN-VITRO AND IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA

      Biochemical pharmacology
    28. NAKAJIMA M; YOKOI T; MIZUTANI M; SHIN S; KADLUBAR FF; KAMATAKI T
      PHENOTYPING OF CYP1A2 IN JAPANESE POPULATION BY ANALYSIS OF CAFFEINE URINARY METABOLITES - ABSENCE OF MUTATION PRESCRIBING THE PHENOTYPE INTHE CYP1A2 GENE

      Cancer epidemiology, biomarkers & prevention
    29. OGURI K; YAMADA H; YOSHIMURA H
      REGIOCHEMISTRY OF CYTOCHROME-P450 ISOZYMES

      Annual review of pharmacology and toxicology
    30. SINHA R; ROTHMAN N; BROWN ED; MARK SD; HOOVER RN; CAPORASO NE; LEVANDER OA; KNIZE MG; LANG NP; KADLUBAR FF
      PAN-FRIED MEAT CONTAINING HIGH-LEVELS OF HETEROCYCLIC AROMATIC-AMINESBUT LOW-LEVELS OF POLYCYCLIC AROMATIC-HYDROCARBONS INDUCES CYTOCHROMEP4501A2 ACTIVITY IN HUMANS

      Cancer research
    31. KOYMANS L; DENKELDER GMD; TEKOPPELE JM; VERMEULEN NPE
      GENERALIZED CYTOCHROME P450-MEDIATED OXIDATION AND OXYGENATION REACTIONS IN AROMATIC SUBSTRATES WITH ACTIVATED N-H, O-H, C-H, OR S-H SUBSTITUENTS

      Xenobiotica
    32. KNAAK JB; ALBAYATI MA; RAABE OG; BLANCATO JN
      DEVELOPMENT OF INVITRO V(MAX) AND K(M) VALUES FOR THE METABOLISM OF ISOFENPHOS BY P-450 LIVER-ENZYMES IN ANIMALS AND HUMAN

      Toxicology and applied pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 08:41:38